The Role of Clinical Suspicion in Evaluating a New Diagnostic Test for Active Tuberculosis: Results of a Multicenter Prospective Trial
The DOI matches its Crossref record.
Abstract
CONTEXT: In laboratory trials, nucleic acid amplification tests for the diagnosis of tuberculosis (TB) are more accurate than acid-fast bacilli (AFB) smear microscopy and are faster than culture. The impact of these tests on clinical diagnosis is not known. OBJECTIVE: To assess the performance of a nucleic acid amplification test, the enhanced Mycobacterium tuberculosis Direct (E-MTD) test, against a uniform clinical standard stratified by level of clinical suspicion. DESIGN: Prospective multicenter trial conducted between February and December 1996, documenting the clinical suspicion of TB at enrollment and using final comprehensive diagnosis as the criterion standard. SETTING: Six urban medical centers and 1 public health TB clinic. PATIENTS: A total of 338 patients with symptoms and signs consistent with active pulmonary TB and complete clinical diagnosis were stratified by the clinical investigators to be at low (< or =25%), intermediate (26%-75%), or high (>75%) relative risk of having TB. MAIN OUTCOME MEASURES: Sensitivity, specificity, and positive and negative predictive values of the E-MTD test in clinical suspicion of groups with low (n = 224); intermediate (n = 68); and high (n = 46) clinical suspicion of TB. RESULTS: Based on comprehensive clinical diagnosis, sensitivity of the E-MTD test was 83%, 75%, and 87% for low, intermediate, and high clinical suspicion of TB, respectively, and corresponding specificity was 97%, 100%, and 100% (P = .25). Positive predictive value of the E-MTD test was 59% (low), 100% (intermediate), and 100% (high) compared with 36% (low), 30% (intermediate), and 94% (high) for AFB smear. Corresponding negative predictive values were 99%, 91%, and 55% [corrected] (E-MTD test) vs 96%, 71%, and 37% (AFB smear). CONCLUSIONS: For complex diagnostic problems like TB, clinical risk assessments can provide important information regarding predictive values more likely to be experienced in clinical practice. For this series, a clinical suspicion of TB was helpful in targeting areas of the clinical spectrum in which nucleic acid amplification tests can make an important contribution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection
Dinnes, J., Deeks, J., Kunst, H., Gibson, A., Cummins, E., Waugh, N., Drobniewski, F., & Lalvani, A. (2007) · Health Technology Assessment · doi:10.3310/hta11030 · Cited by 666
Exploring sources of heterogeneity in systematic reviews of diagnostic tests
Lijmer, J. G., Bossuyt, P. M. M., & Heisterkamp, S. H. (2002) · Statistics in Medicine · doi:10.1002/sim.1185 · Cited by 446
Pai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2508001 · Cited by 273
Metadata
- Authors
- Catanzaro, A., Perry, S., Clarridge, J. E., Dunbar, S., Goodnight-White, S., LoBue, P. A., Peter, C., Pfyffer, G. E., Sierra, M. F., Weber, R., Woods, G., Mathews, G., Jonas, V., Smith, K., & Della-Latta, P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2000-02-02
- Volume
- 283
- Issue
- 5
- Pages
- 639
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2168501681
- Cited by
- 152
- References
- 0
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Clinical Suspicion in Evaluating a New Diagnostic Test for Active Tuberculosis: Results of a Multicenter Prospective Trial. https://app.cochat.ai/papers/10.1001/jama.283.5.639
- The paper
- Catanzaro, A., Perry, S., Clarridge, J. E., Dunbar, S., Goodnight-White, S., LoBue, P. A., Peter, C., Pfyffer, G. E., Sierra, M. F., Weber, R., Woods, G., Mathews, G., Jonas, V., Smith, K., & Della-Latta, P. (2000). The Role of Clinical Suspicion in Evaluating a New Diagnostic Test for Active Tuberculosis: Results of a Multicenter Prospective Trial. JAMA. https://doi.org/10.1001/jama.283.5.639
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.